NIH-funded research Career grant

Measuring serotonin and adenosine in spinal fluid to identify injuries in spinal cord injury patients

Official title: Cerebral spinal fluid serotonin and adenosine levels detect secondary injuries in traumatic spinal cord injury patients

Funded at University of Pittsburgh at Pittsburgh · NIH-10887104 · Data updated 2026-11-12

This study is looking at the levels of certain chemicals in the fluid around the spine of people who have had spinal cord injuries, to see if they can help us understand and prevent further damage after the injury, with the hope of improving recovery for patients.

More Spinal Cord Injury research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$111,307
NIH project number1K99GM159353-01
Project IDNIH-10887104 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have recently experienced a traumatic spinal cord injury.

Less likely to help

Patients with chronic spinal cord injuries or those who do not have measurable levels of serotonin and adenosine in their cerebrospinal fluid may not benefit from this research.

What this research studies

This research investigates the levels of serotonin and adenosine in the cerebrospinal fluid of patients with traumatic spinal cord injuries. By analyzing these biomarkers, the study aims to detect secondary injuries that occur after the initial trauma, which can worsen patient outcomes. The research will involve collecting and analyzing patient samples to establish a connection between these biomarkers and the severity of secondary injuries. The ultimate goal is to develop strategies that can mitigate these secondary injuries and improve rehabilitation outcomes for patients.

Why it matters

Potential benefit: If successful, this research could lead to improved methods for identifying and treating secondary injuries in spinal cord injury patients, enhancing their recovery and quality of life.

How similar studies have gone: While the specific approach of using serotonin and adenosine as biomarkers for secondary injuries is novel, similar studies have shown promise in identifying biomarkers for other types of injuries.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Fields, Daryl — University of Pittsburgh at Pittsburgh
  • Study coordinator: Fields, Daryl

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.